WebFeb 1, 2024 · For oral dosage form (suspension): For diarrhea or upset stomach: Adults and teenagers—The usual dose is 2 tablespoonfuls every half-hour to one hour if needed. You should not take more than 16 tablespoonfuls of the regular-strength suspension or 8 tablespoonfuls of the concentrate in twenty-four hours. WebPeople aged 12 years and older: The typical dose is 30 mL (525 mg) by mouth every 30 minutes as needed for up to 2 days. If you’re taking bismuth subsalicylate (Pepto-Bismol) to treat diarrhea, you can take 60 mL (1,050 mg) by mouth every 60 minutes instead. Don’t take more than 240 mL (4,200 mg) in a day.
nhc-charleston.tricare.mil
WebAlum-mag hydroxide-simethicone 400-400-40 mg/5ml suspension Bismuth subsalicylate 262 mg/15ml suspension Bismuth subsalicylate 525 mg/15ml suspension Calcium carbonate (antacid) 1250 mg/5ml suspension ... (8000 unit/ml) solution Ferrous sulf 75 mg/ml (15 mg elemtl Fe) solution Ferrous sulf 220 mg/5ml (44 mg elemtl Fe) elixir WebJul 9, 2015 · Oral suspensions of bismuth subsalicylate are available over-the-counter containing 262 milligrams (mg) per 15 ml (one tablespoon), or 525 mg per tablespoon in the “extra strength” form. … cycloplegics and mydriatics
Bismuth Subsalicylate (Pepto-Bismol®, Kaopectate®) …
WebOct 31, 2024 · Drug Facts. Active ingredient (in each 15 mL dose) Bismuth subsalicylate 525 mg. Purpose. Upset stomach reliever and antidiarrheal. Uses. relieves - traveler's diarrhea - diarrhea - upset stomach due to overindulgence in food and drink, including: heartburn - indigestion - nausea - gas - belching - fullness. Warnings. WebAdults: The recommended dosages are: bismuth subsalicylate, 525 mg (two 262.4 mg-chewable tablets), metronidazole, 250 mg (one 250-mg tablet), and tetracycline hydrochloride, 500 mg (one 500-mg capsule) taken four times daily for 14 days plus an H 2 antagonist approved for the treatment of acute duodenal ulcer. Patients should be … WebApr 8, 2024 · Given failure to eradicate H. pylori with 7 different antibiotic regimens despite adherence to treatment, suppressive therapy with bismuth subsalicylate 262 mg, 2 chewable caplets twice a day as monotherapy, was initiated. After 2 months on bismuth subsalicylate therapy, the patient reported marked improvement in her abdominal … cyclopithecus